June 20, 2007 — A large, international clinical trial in teens with schizophrenia demonstrated that the atypical antipsychotic aripiprazole (Abilify, Otsuka Pharmaceutical Co and Bristol-Myers Squibb) ...

Abstract and Introduction Clinical Profile of Aripiprazole as Reflected by Clinical Trial Data Use of Aripiprazole in the Treatment of Schizophrenia: Consensus Report Conclusion References Control of ...

PRINCETON, N.J. & TOKYO--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd., announced today that the U.S. Food and Drug Administration (FDA) has approved ...

PRINCETON, N.J. & DEERFIELD, Ill.--(BUSINESS WIRE)--Otsuka Pharmaceutical Co., Ltd (Otsuka) and H. Lundbeck A/S (Lundbeck) published results from research demonstrating that an investigational ...

ABILIFY® (Aripiprazole) Injection for Intramuscular Use for Adults With Agitation Associated With Schizophrenia or Bipolar Mania Now Available - Provides Rapid Control of Agitation - December 12, 2006 ...

Compared with initiation of another antipsychotic drug, starting aripiprazole after prior antipsychotic exposure was not associated with psychiatric hospitalization, self-harm or suicide in a ...

Subject to final approval by the European Commission, the drug will be the first once-every-two-months long-acting injectable (LAI) antipsychotic licensed in the EU for adult patients with ...

If approved, aripiprazole 2-month ready-to-use (RTU), long-acting injectable (LAI) would be the first 2-month, LAI antipsychotic indicated for both treatment of schizophrenia and the maintenance ...

schizo cropped The FDA issued a warning that the use of aripiprazole has been linked to compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex. These impulse-control problems were ...

Hannah Furfaro was a writer at Spectrum News from 2017 to 2019. She previously worked at The Wall Street Journal, The Fresno Bee, and the Associated Press; her work has also appeared in The Guardian ...